IL6 and diabetes mellitus: Previous studies have suggested that phospho-p38 MAPK expression is downregulated by resveratrol, which has been shown to ameliorate diabetes-induced cardiac dysfunction [42], interleukin-6 release in PC12 cells [43], and oxidized low-density lipoprotein-induced macrophage apoptosis [44].